Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 24
Healthy volunteers: yes

Brief summary:
The objective of the study is to investigate the relative bioavailability of the final tablet formulation (FF) of BI 10773 in comparison to the tablet formulation 2 (TF2).

Detailed description:

Arms:
arm 1: one single film-coated tablet in the morning arm 2: one single dose tablet in the morning

Interventions: intervention 1: BI 10773 XX (Trial Formulation 2) intervention 2: BI 10773 (Final Formulation)
Intervention descriptions: intervention 1: one single dose tablet in the morning intervention 2: one single film-coated tablet in the morning

Protocol document: